Checkpoint Therapeutics Inc
NASDAQ:CKPT
Checkpoint Therapeutics Inc
NASDAQ:CKPT
Price:
4.26
USD
0.71%
Market Cap:
$370.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Checkpoint Therapeutics Inc
NASDAQ:CKPT
|
US |
|
Innovatec SpA
MIL:INC
|
IT |
|
H
|
Hota Industrial Mfg. Co Ltd
TWSE:1536
|
TW |
|
Rouchon Industries Inc
OTC:RCHN
|
US |
|
S
|
Singapore Technologies Engineering Ltd
OTC:SGGKF
|
SG |
|
Shanghai Shen Lian Biomedical Corp
SSE:688098
|
CN |
|
M
|
Maagh Advertising & Marketing Services Ltd
BSE:543624
|
IN |
|
Allied Minds PLC
LSE:ALM
|
UK |
|
Nice Corp
TSE:8089
|
JP |
|
Weizmann Limited
NSE:WEIZMANIND
|
IN |
|
Zhejiang Weixing Industrial Development Co Ltd
SZSE:002003
|
CN |
|
Westport Fuel Systems Inc
TSX:WPRT
|
CA |
|
G
|
Gridwiz Co Ltd
KOSDAQ:453450
|
KR |
|
D
|
DMC Mining Ltd
ASX:DMM
|
AU |
|
S
|
Samkee Energy Solutions Co Ltd
KOSDAQ:419050
|
KR |
|
C
|
Coeptis Therapeutics Inc
NASDAQ:COEP
|
US |
Multiples-Based Value
The Multiples-Based Value of one
CKPT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 4.26 USD,
Checkpoint Therapeutics Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CKPT Multiples-Based Value
LOCKED
Multiples Across Competitors
CKPT Competitors Multiples
Checkpoint Therapeutics Inc Competitors
Checkpoint Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Checkpoint Therapeutics Inc
NASDAQ:CKPT
|
356.8m USD | 8 703.3 | -6.3 | -5.8 | -5.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6.1 | 88.8 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 6.2 | -96.2 | 951.3 | -107.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.6 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20.1 | 12.6 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.7 | 29.3 | 22.1 | 23.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.6 | 17.8 | 13.3 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
